Mp15-16 the Association of Age With Perioperative and Clinicopathologic Outcomes Following Radical Cystectomy for Non-muscle Invasive Bladder Cancer
Year: 2017
Type: article
Abstract: CONCLUSIONS: Cabazitaxel, gemcitabine and cisplatin appears to be a well-tolerated intravesical salvage chemotherapy regimen for the treatment of BCG-refractory non-muscle invasive bladder cancer.
Source: The Journal of Urology
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2604858157
